This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Method Article
PISA screening protocol - A protocol for the selection of intracellular antibodies against post-translational modifications of native proteins
License:
This work is licensed under a CC BY-NC 3.0 License. Read Full License
Protein post-translational modifications (PTMs) represent an untapped source of targets of huge biological interest and therapeutic potential. Their validation can only be indirect, because PTMs cannot be selectively hit by nucleic-acid based interference approaches. Here we describe the protocol for Post-translational Intracellular Silencing Antibody technology (P.I.S.A.), a method for the selection of intrabodies targeting the native acetylated version of proteins and their use for PTM-selective targeting and functional interference in living cells.
Keywords
intrabodies, post-translational modifications, two-hybrid, IACT, PISA, intracellular antibodies
Figure 1
Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
- supplement0.docx
Table 1 Sequences of validated acetylase domains and linkers Sequences of validated acetylase domains and linkers
- supplement0.docx
Reagents, media, solutions, equipment Reagents, media, solutions, equipment
- supplement0.docx
PISA screening protocol PISA screening protocol
Mascia Laura
commented on 15 October, 2020
In the Reagents section the YPA medium has the same composition of the YPAD one.
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 17 Jan, 2017
Community comments: 1
Metrics
Comments: 1
HTML Views: ...
Associated Publications
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies
by Michele Chirichella, Simonetta Lisi, Marco Fantini, +7
Nature Methods (17 January, 2017)
Learn more about our company.
This is a preprint. It has not completed peer review.
Method Article
PISA screening protocol - A protocol for the selection of intracellular antibodies against post-translational modifications of native proteins
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 17 Jan, 2017
Community comments: 1
Metrics
Comments: 1
HTML Views: ...
License:
This work is licensed under a CC BY-NC 3.0 License. Read Full License
Protein post-translational modifications (PTMs) represent an untapped source of targets of huge biological interest and therapeutic potential. Their validation can only be indirect, because PTMs cannot be selectively hit by nucleic-acid based interference approaches. Here we describe the protocol for Post-translational Intracellular Silencing Antibody technology (P.I.S.A.), a method for the selection of intrabodies targeting the native acetylated version of proteins and their use for PTM-selective targeting and functional interference in living cells.
Figure 1
Figure 2
Mascia Laura
commented on 15 October, 2020
In the Reagents section the YPA medium has the same composition of the YPAD one.
Associated Publications
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies
by Michele Chirichella, Simonetta Lisi, Marco Fantini, +7
Nature Methods (17 January, 2017)